Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hansen

Showing results (1421-1430 of 1,581) with videos related to

Pageof 159
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck CancerEnrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, et al.
The Lancet. Oncology|March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid TumorsMaria Vieito, Victor Moreno, Anna Spreafico, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2023
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)A Spreafico, A A Heirali, D V Araujo, et al.
The EMBO Journal|June 17, 2024
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stressDylan F Fingerman, David R O'Leary, Ava R Hansen, et al.
Biology of Reproduction|August 4, 2023
Induced endometrial inflammation compromises conceptus development in dairy cattle†Ali Husnain, Usman Arshad, Roney Zimpel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2019
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal CancerAstrid Billfalk-Kelly, Eugene Yu, Jie Su, et al.
Plos One|November 5, 2016
Genetic Variation within Clonal Lineages of Phytophthora infestans Revealed through Genotyping-By-Sequencing, and Implications for Late Blight EpidemiologyZachariah R Hansen, Kathryne L Everts, William E Fry, et al.
Clinical Proteomics|July 27, 2022
Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AMLSara J C Gosline, Cristina Tognon, Michael Nestor, et al.
Pageof 159

Showing results (1421-1430 of 1,581) with videos related to

Sort By:
Pageof 159
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck CancerEnrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce, et al.
The Lancet. Oncology|March 20, 2026
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)Emily Alger, Antoine Regnault, Amylou C Dueck, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trialsY Kanjanapan, D Day, M O Butler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2023
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid TumorsMaria Vieito, Victor Moreno, Anna Spreafico, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2023
First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial)A Spreafico, A A Heirali, D V Araujo, et al.
The EMBO Journal|June 17, 2024
The SMC5/6 complex prevents genotoxicity upon APOBEC3A-mediated replication stressDylan F Fingerman, David R O'Leary, Ava R Hansen, et al.
Biology of Reproduction|August 4, 2023
Induced endometrial inflammation compromises conceptus development in dairy cattle†Ali Husnain, Usman Arshad, Roney Zimpel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 7, 2019
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal CancerAstrid Billfalk-Kelly, Eugene Yu, Jie Su, et al.
Plos One|November 5, 2016
Genetic Variation within Clonal Lineages of Phytophthora infestans Revealed through Genotyping-By-Sequencing, and Implications for Late Blight EpidemiologyZachariah R Hansen, Kathryne L Everts, William E Fry, et al.
Clinical Proteomics|July 27, 2022
Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AMLSara J C Gosline, Cristina Tognon, Michael Nestor, et al.
Pageof 159